Munich Reinsurance Co Stock Corp in Munich Takes $2.14 Million Position in Waters Corporation $WAT

Munich Reinsurance Co Stock Corp in Munich purchased a new stake in Waters Corporation (NYSE:WAT) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 7,151 shares of the medical instruments supplier’s stock, valued at approximately $2,144,000.

A number of other hedge funds have also recently added to or reduced their stakes in WAT. Brighton Jones LLC lifted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC increased its stake in shares of Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after purchasing an additional 160 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Waters in the 2nd quarter valued at $232,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Wednesday, January 21st. Evercore started coverage on Waters in a report on Tuesday, February 10th. They set a “hold” rating and a $360.00 target price on the stock. Robert W. Baird set a $363.00 price target on Waters in a research note on Tuesday, February 10th. William Blair began coverage on Waters in a report on Monday, January 5th. They set an “outperform” rating on the stock. Finally, Wolfe Research raised Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price objective on the stock in a research note on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, Waters currently has an average rating of “Moderate Buy” and a consensus target price of $393.84.

Waters Price Performance

Shares of WAT stock opened at $302.44 on Friday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The company has a market capitalization of $29.67 billion, a P/E ratio of 28.08, a P/E/G ratio of 2.08 and a beta of 1.20. The stock has a 50 day moving average of $361.44 and a two-hundred day moving average of $351.27. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37.

Waters (NYSE:WAT) last released its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. The business had revenue of $932.36 million for the quarter, compared to analysts’ expectations of $928.17 million. Waters had a return on equity of 34.79% and a net margin of 20.30%.Waters’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the business posted $4.10 earnings per share. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, equities analysts expect that Waters Corporation will post 12.86 EPS for the current year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.